肥胖的系统影响:探索与糖尿病,心血管疾病和心力衰竭的分子和生理联系
Dipanjan Banerjee1, Arya Mani1,2
1Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.
Frontiers in endocrinology
|November 24, 2025
概括
肥胖问题 肥胖问题
科学领域:
- 内分泌学和新陈代谢学
- 心血管科学 心血管科学
- 分子生物学分子生物学
背景情况:
- 全球肥胖率的上升增加了医疗保健负担.
- 肥胖的原因涉及复杂的遗传,表观遗传和环境相互作用.
- 了解肥胖和并发症之间的分子联系至关重要.
研究的目的:
- 审查最近对与肥胖相关的并发病的机制性见解.
- 阐明将脂肪组织扩张与疾病联系起来的分子途径.
- 弥合肥胖症病理生理学的知识差距.
主要方法:
- 全面的文献搜索和综合最近的发现.
- 专注于分子机制和病理生理途径.
- 分析肥胖对2型糖尿病和心血管疾病的影响.
主要成果:
- 关键途径包括炎症,胰岛素耐药性,阿迪波金失调和补充激活.
- 这些途径将肥胖与2型糖尿病,心血管疾病和代谢综合征联系起来.
- 肥胖引起的心脏结构和功能变化有助于心力衰竭.
结论:
- 肥胖与并发症的联系是复杂的和多因素的.
- 针对性干预需要对分子机制有更深入的理解.
- 识别可用药的途径可以改善对肥胖及其并发症的管理策略.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Coronary Artery Disease I: Introduction
857
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
857
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
228
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
228
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Carbohydrate Metabolism
13.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.7K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
162
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
162


